Does glipizide treatment of post-transplant diabetes interfere with cyclosporine pharmacokinetics in renal allograft recipients?
CsA pharmacokinetics is not significantly altered by glipizide coadministration.
6-SG has barrier-protective effects by affecting TNF-α-induced claudin-2 upregulation and claudin-1 disassembly via inhibition of phoshatidylinositol-3-kinase/Akt and nuclear factor kappa light chain enhancer of activated B-cell signaling. Therefore, 6-SG-containing food might be beneficial for barrier preservation during intestinal inflammation.